Still, if you have been a regular smoker, you will probably go through unpleasant experiences. Seeing professionals like the Providence Projects team is one of the ways to equip yourself with knowledge and tools required to combat CWS. If you’re experiencing negative symptoms while trying to quit cannabis, you’re not alone. Research suggests that about 47 per cent of the people who regularly use cannabinoids experience at least some type of withdrawal. In many of the instances, withdrawal contributed to clinically-significant symptoms that were disruptive enough to interfere with a person’s daily existence.
Cannabis Withdrawal Syndrome (CWS)
Several lines of evidence from human studies indicate that cessation from long-term and regular cannabis use precipitates a specific withdrawal syndrome with mainly mood and behavioral symptoms of light to moderate intensity, which can usually be treated in an outpatient setting. However, comorbidity with mental or somatic disorders, severe CUD, and low social functioning may require an inpatient treatment (preferably a qualified detox) and post-acute rehabilitation or long-term outpatient care. There are promising results with gabapentin and THC analogs in the treatment of CWS. Certainly, further research is required with respect to the impact of the CWS treatment setting on long-term CUD prognosis and with respect to psychopharmacological or behavioral approaches, such as aerobic exercise therapy or psychoeducation, in the CWS treatment. The preliminary up-to-date content for the ICD-1133 (intended to be finally published in 2018) is recommended to be expanded by physical CWS-symptoms, the specification of CWS severity and duration as well as gender effects.
Worse, frequent ED consultations have been shown to lead to cognitive bias from teams, which could trivialize symptoms and result in missed alternative diagnoses 45. In light of these factors, and based on the above literature review, we proceeded to review the management of chronic cannabis users presenting to our ED with hyperemesis, nausea, and/or abdominal pain. In a bid to share with other acute care units, we will now present our internal guidelines, reflecting the current level of evidence. Subjects received a list of 40 possible cannabis withdrawal symptoms drawn from the published literature (Levin et al., 2010).
Some Heavy Cannabis Users Experience Withdrawal After Quitting
Marijuana Anonymous confirms that many of their “recovering members have had definite withdrawal symptoms.” Their treatment program values progress over perfection when overcoming cannabis dependency and detoxing from marijuana. They perceive it as a personal and physical struggle, rather than a scientific one. Cannabis withdrawal syndrome (CWS) was newly added to the Diagnostic and Statistical Manual of Mental Disorders in its most recent edition, DSM-5.
Table of Contents
They can come and go depending upon availability of supply, the user’s ability to afford marijuana, and most poignantly, when they decide to fight their dependency or addiction to weed. 12-month frequent tobacco users experiencing withdrawal symptoms similar to DSM-5 cannabis withdrawal symptoms, which occurred after reduction or cessation of tobacco use. Multiple studies have demonstrated a positive association between intensity of cannabis use and rates of withdrawal (Stephens, Addiction, 2002; Copeland, J Subst Abuse Treat, 2001). If you are a heavy user, or if you use other substances like alcohol, tobacco, or cocaine, or have a co-morbid psychiatric diagnosis, you may consider consulting with your doctor or other healthcare provider so that you can be monitored for symptoms of severe withdrawal.
Some of these drugs, like dronabinol or nabiximol, are similar to THC, the active ingredient in marijuana—if you choose to take these medications, you will still test positive for cannabinoids in drug tests. Importantly, there are no medications that are FDA-approved for treatment of marijuana withdrawal. If you require medication for severe withdrawal, make sure to consult with your doctor to determine which drug, if any, is best suited for you. No studies have evaluated the treatment of abdominal pain, as its incidence in CWS is significantly less than in CHS. Furthermore, in light of the pathophysiological processes behind CWS, its presence may not be a direct consequence to THC but simply a response to emesis (and if present, may be a sign that the patient is experiencing CHS rather than CWS). Thus, if present, it should theoretically be manageable with conventional non-opioid analgesics and anticholinergics (such as butylscopolamine), the latter having the advantage of increasing dopamine concentrations in the brain.
Comorbidity with mental or somatic disorders, severe CUD, and low social functioning may require an inpatient treatment (preferably qualified detox) and post-acute rehabilitation. There are promising results with gabapentin and delta-9-tetrahydrocannabinol analogs in the treatment of CWS. According to small studies, venlafaxine can worsen the CWS, whereas other antidepressants, atomoxetine, lithium, buspirone, and divalproex had no relevant effect. Certainly, further research is required with respect to the impact of the CWS treatment setting on long-term CUD prognosis and with respect to psychopharmacological or behavioral approaches, such as aerobic exercise therapy or psychoeducation, in the treatment of CWS. The up-to-date ICD-11 Beta Draft is recommended to be expanded by physical CWS symptoms, the specification of CWS intensity and duration as well as gender effects. The cannabis withdrawal syndrome (CWS) is a criterion of cannabis use disorders (CUDs) (Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition) and cannabis dependence (International Classification of Diseases ICD-10).
- All data generated or analyzed during this study are included in this published article.
- “We worked with a number of behavioral approaches” in his research, including anticipating difficulties with mood and sleeping, and planning activities—everything from exercise to a warm glass of milk—that can alleviate the difficulties.
- However, prospective studies are needed to understand the directionality of these relationships.
- This means being a daily smoker, or if you have used more than 3 times a week for a year or more.
- Protocols using oral THC 31, 32, dronabinol 33, or nabiximols 34 have shown an improvement of withdrawal symptoms (altered mood and sleep, nausea and craving) and an increase in prolonged abstinence.
The Cost of Alcohol Addiction: Emotional, Financial, and Social Impacts
The severity of the symptoms varies, but they usually have light to moderate intensity. But if you ask a regular guy posting on Reddit, he would say that his withdrawal symptoms weren’t withdrawal symptoms at all. What would be defined as “withdrawal” by some, he would define as boredom, focusing more on the differences in perception between being high and being sober. It is the first to examine the prevalence and correlates of DSM-5 CWS in the adult US general population. Focusing on diagnoses of CWS in the past 12 months reduced the possibility of recall bias, improving the quality of data compared to prior lifetime reports.
Patients presenting with hyperemesis and abdominal pain should be thoroughly examined, the potential for dehydration, prerenal acute kidney injury, and dyselectrolytemia being on the initial preoccupations for acute care. With the added advantage that hydration and electrolyte substitution may reduce symptomatology 15, the next step is focusing on specifically addressing nausea and hyperemesis. In light of differing pathological processes, the choice of agent should be tailored to the suspected diagnosis, hence the importance of obtaining a thorough medical history. In patients predisposed to symptoms, overstimulation of said receptors may result in increased gastric acid secretion and impaired gut motility and relaxation of the gastro-esophageal sphincter, as well as dysregulated basal sympathetic activity, altogether resulting in hyperemesis.
Having helped over 10,000 people overcome their addiction, we’re confident in the effectiveness of our tailored, holistic approach. Providence Projects has been dealing with addiction recovery over the course of 25 years. Let us guide you through the confusing CWS phase and cws symptoms equip you with the tools needed to make your journey easier and successful in the long run. If you are struggling to quit weed, or have made previous attempts to stop, we offer residential detox to help you on the road to recovery. To help you resist future temptations, we will work with you to create effective coping skills.
Outpatient therapy
- Institutional review boards at the National Institutes of Health and Westat (NESARC-III contractor) approved the study protocol.
- If you have a personal or family history of psychiatric illness, including anxiety, depression, or other substance use, you are likely at an increased risk for CWS.
- It remains a challenge of future in-depth studies to compare the impact of outpatient and inpatient treatment programs on the long-term course and disability of substance use disorders, which applies to CUD, too.
- Thus, we consider it unlikely that our results were due to subjects mistaking other substance withdrawal for cannabis withdrawal.
- Patients presenting with hyperemesis and abdominal pain should be thoroughly examined, the potential for dehydration, prerenal acute kidney injury, and dyselectrolytemia being on the initial preoccupations for acute care.
We conducted a secondary analysis of these data to evaluate the prevalence and concurrent and predictive validity of the proposed DSM-V criteria for CWS. These data also provide empirical evidence to address some diagnostic issues raised in the DSM-V proposal. In short, you are at higher risk for marijuana withdrawal if you are a heavy marijuana user. This means being a daily smoker, or if you have used more than 3 times a week for a year or more. As we previously illustrated, multiple studies have demonstrated a positive association between intensity of cannabis use and rates of withdrawal (Stephens, Addiction, 2002; Copeland, J Subst Abuse Treat, 2001).
“There might be a sense that cannabis use disorder and CWS are not “real” addictions. If this is true, then there might be some trivialization of CWS,” Bahji tells Inverse. There has also been research (2010) that suggests some symptoms of CWS could be inherited. Scientists suspect that the longitude and intensity of CWS could be closely related to genetic factors. On the other hand, the most persistent symptom can be recurring wild and strange dreams, which can last for months.
CWS, on the other hand, tends to present in chronic users within 1–10 days after last THC intake, with a peak incidence between days 2 and 6. No correlation has been established between symptoms severity and quantity (of THC) previously consumed, and initial presentation (to acute care) tends to vary, with a clinical course not well defined. Symptoms, which include nausea and vomiting as well as psychological and other somatic issues, generally worsen the further the patient is from last consumption, and can last up to 4 weeks. This likely corresponds to the time needed for CB1 receptors to return to their original state in the central dopaminergic pathways; this important feature is key to long-term management of these patients, who require ambulatory follow-up rather than simple symptomatic relief 13.
These features characterize a number of conditions, which means doctors might misdiagnose withdrawal as a different psychiatric condition. Some are the very reasons people turn to smoking weed in the first place (sleeping problems jump to mind, even if it’s not a sustainable solution). People smoke marijuana for lots of reasons, from breaking up workouts to calming anxiety.
“Clearly, there’s some part of the population for whom withdrawal is unpleasant.” He recommends working with a physician who can help the patient through the process, which could include a short-term prescription for a sleeping aid or mood stabilizer. It may be easier to taper off when the cannabinoid delivery vehicle (Sativex is usually taken as an oral spray) differs from the cannabis routine to which a patient has grown accustomed. Just as it’s easier to quit tobacco by using a transdermal patch, rather than tapering off cigarettes, it may be easier to ease out of a cannabis routine by using a different form of intake. After four weeks, cannabinoid receptors in the brain return to normal function and withdrawal ends.